Current status: Answered by Jenni Minto on 17 December 2025
To ask the Scottish Government what steps it is taking to reduce adult patient waiting times for access to diabetes technology.
We are committed to ensuring that everyone living with diabetes can access clinically appropriate, safe, effective and person-centred care. We know that waiting times for access to diabetes technologies, such as Closed Loop Systems (CLS), remain a challenge, and we are taking action to improve this.
Since 2016, the Scottish Government has invested over £50 million to support technology access, including:
These measures increase capacity and reduce delays by enabling virtual onboarding and freeing up local clinic resources. In addition, the National Onboarding Team, hosted by NHS Golden Jubilee, provides virtual education and training, enabling people anywhere in Scotland to start using diabetes technologies without delay. This innovative model supported almost 1,000 people last year with a 100% satisfaction rate.
The National CLS Onboarding Programme has enabled more than 4,200 people to receive CLS since May 2024. As of September 2025, 77% of under-18s with Type 1 diabetes have access to CLS, and every child or young person should have received at least a referral. This paediatric focus helps prevent complications early and reduce future backlogs.
This builds on Scotland’s strong progress in diabetes technology adoption. According to the 2024 Diabetes Survey, insulin pump use has risen to 23.2% of all people with Type 1 diabetes, up from just 6.3% in 2013. Continuous Glucose Monitoring (CGM) adoption has increased to 85.7% in 2024, compared to 82.5% in 2023, reflecting Scotland’s commitment in digital diabetes care.
We will continue to work with boards to reduce variation and waiting times through targeted funding and performance-based delivery models that prioritise equitable access for all.